Tyler Seibert: cT3 is No Longer Universally Understood for Prostate Cancer
Tyler Seibert, Radiation Oncologist and Cancer Scientist at UC San Diego, shared on X: “cT3 is no longer universally understood for Prostate Cancer – meaning differs widely. If trying to […]
Read the full articleYou might also wanna read
Two-isotope imaging could guide targeted alpha therapy for metastatic prostate cancer
Prostate cancer is one of the most common cancers affecting men worldwide. However, planning personalized radiotherapy in the advanced stage
Study: Imaging scans detect prostate cancer progression missed by stable PSA levels
Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of prostate-specific an
news-medical.net·14d ago
Are imaging-cautious ordering physicians a ‘dying breed’?
David Canes, MD, a Massachusetts-based urologist, posed the question on social media July 8, garnering over 100 responses from radiologists
Phase 3 trial: PSMA-PET-CT may help some high-risk men avoid prostate biopsy
Phase 3 data suggest PSMA-PET-CT could reduce unnecessary prostate biopsies in selected high-risk men, though longer follow-up is needed.
mdsc.pe·15d ago
From MMA Fighter to Radiation Oncologist: Combating Prostate Cancer
Daniel Spratt, MD discusses the obstacles of prostate cancer and shares breakthroughs and achievements.
AI-Driven Biomarker Predicts Prostate Cancer Outcomes
The tool, based on histology only, may help identify patients most likely to benefit from triplet therapy. Medscape Medical News
Comments
Sign in to join the conversation.
No comments yet. Be the first.